Humanetics Corporation to Participate in Benchmark Healthcare Investor Conference This Week MINNEAPOLIS -- (BUSINESS WIRE) -- Humanetics Corporation has announced that its executive management team will participate in the Benchmark Company’s 5th Annual Healthcare House Call Virtual Investor Conference. The event is scheduled for Thursday, May 29th, and Humanetics will present during the 1:30 PM to 2:10 PM Eastern Time slot. The Benchmark Healthcare House Call Virtual Investor Conference provides a platform for industry leaders to share insights and updates with investors. Humanetics Corporation's involvement in this conference highlights its commitment to keeping stakeholders informed about its progress and strategic initiatives. About Humanetics Corporation Humanetics Corporation is a clinical-stage pharmaceutical company dedicated to the rapid discovery, development, and commercialization of proprietary drugs aimed at addressing urgent and unmet medical needs. The company’s primary focus is on radiation modulators for oncology and medical countermeasures. Radiation modulators are crucial in enhancing the effectiveness of radiation therapy in cancer treatment and in protecting against radiation exposure in various medical and environmental contexts. For more information about Humanetics Corporation and its innovative projects, visit their website at www.humaneticscorp.com.